Some of Alkermes Contract Pharma Services’ patented oral delivery technologies include:
Multiparticulate delivery system, providing tailored, highly flexible release profiles including controlled release, delayed release, immediate release and pulsatile release of drug.
Controlled release tablet technology, designed for use with more gastrointestinal irritant compounds.
Multiparticulate minitablet technology system, which combines the benefits of tableting technology within a capsule.
Hydrophilic matrix technology which controls the release of drug through a process of diffusion and erosion in the gastrointestinal tract.
Bilayer tablet which can provide immediate or sustained release of two drugs or different release rates of the same drug in one dosage form.
If you would like to discuss these or other of Alkermes Contract Pharma Services' customized and patented technology approaches, please contact us.
You are now leaving Alkermes.com.
